The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye

Nicole L. Lanza, Felipe Valenzuela, Victor L Perez Quinones, Anat Galor

Research output: Contribution to journalArticle

18 Scopus citations


Dry eye is a common, multifactorial disease currently diagnosed by a combination of symptoms and signs. However, the subjective symptoms of dry eye poorly correlate to the current gold standard for diagnostic tests, reflecting the need to develop better objective tests for the diagnosis of dry eye. This review considers the role of ocular surface matrix metalloproteinase 9 (MMP-9) in dry eye and the implications of a novel point-of-care test that measures MMP-9 levels, InflammaDry (RPS, Sarasota, FL) on choosing appropriate therapeutic treatments.

Original languageEnglish (US)
Pages (from-to)189-195
Number of pages7
JournalOcular Surface
Issue number2
StatePublished - Apr 1 2016



  • dry eye
  • InflammaDry
  • matrix metalloproteinase 9

ASJC Scopus subject areas

  • Ophthalmology

Cite this